Radiation Oncology Online Review 2018 VIDEO 

Faculty and Topics

Parul Barry, MD – Assistant Professor of Radiation Oncology, Rush University Medical Center – Endometrial Cancer, Cervical Cancer, Vulvar Cancer

Dukagjin Blakaj, MD, Ph.D. – Assistant Professor of Radiation Oncology, Ohio State University – Head and Neck Cancer I – III

Michael Chuong, MD – Practicing Radiation Oncologist, University of South Florida – Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma and Solitary Plasmacytoma

Steven Lin, MD, Ph.D. – Associate Professor of Radiation Oncology, MD Anderson Cancer Center – Early Stage NSCLC, Locally Advanced NSCLC, Small Cell Lung Cancer, Rare Mediastinal Tumors

Victor Mangona, MD – Practicing Radiation Oncologist, Texas Center for Proton Therapy, Irvine, TX – Pediatric Brain Tumors, Brain Stem Glioma, Medulloblastoma, Intracranial Germ Cell Tumors, Ependymoma, Pediatric Gliomas, Pediatric CNS Questions, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Ewing’s Sarcoma, Pediatric Solid Questions

Chirag Shah, MD – Associate Staff Director of Clinical Research, Cleveland Clinic Foundation – Early Stage Breast Cancer, Locally Advanced Breast Cancer, Carcinoma-in-situ and Misc (DCIS)

Ravi Shridhar, MD, PhD† – Associate Professor of Radiation Oncology, University of South Florida – Esophageal Cancer, Gastric Cancer, Colon Cancer, Rectal Cancer, Anal Cancer, Liver Cancer, Pancreatic Ampullary Cancer, Bile Duct Cancer

Todd Swanson, MD, PhD† – Assistant Professor of Radiation Oncology, University of Texas, Galveston – CNS Overview, Primary CNS Malignancies, CNS Metastasis of Brain, CNS Metastasis Spine, Benign disorders of CNS, Palliative Care, Bladder, Penile, Prostate Cancer I, Prostate Cancer II

†Course Planning Committee

Faculty, Planner, and Reviewer Disclosure Declaration

In compliance with the Standards, Guidelines, and Ethical opinions of the ACCME, AAMC and AMA, The Osler Institute requires that anyone with input into the planning or presentation of Continuing Medical Education activities provided or jointly-provided by The Osler Institute must disclose to the program audience any relevant financial relationships with companies or organizations about whose products or services they are discussing in their presentations. 

• The following faculty/planners/reviewers disclosed a relevant financial relationship(s). 

  Michael Chuong, MD – Speaker for Accuray, Inc.
  
  Chirag Shah, MD – Consultant for ImpediMed, In

• The following faculty/planners/reviewers listed no relevant financial relationship(s) to disclose.

  Parul Barry, MD
  
  Dukagjin Blakaj, MD, PhD
  
  Steven Lin, MD, PhD
  
  Victor Mangona, MD
  
  Ravi Shridhar, MD, PhD†*
  
  Todd Swanson, MD, PhD†
  
  Christina Pearison†
  
  Joseph Selliken, MD†
  
  Michael Stewart†Sally 
  
  Schuette, PhD†

  Copies of the Faculty Disclosure Forms are available upon request.
  
  † Program Planning Committee
  
  * Reviewer if Applicable

Learning Objectives

At the conclusion of this course each participant should be able to perform the following tasks for all cancers of the eleven ABR defined component areas:

• Describe the anatomy, epidemiology/etiologic agents, and natural history
• Explain the pathology and use of tumor markers
• Describe the initial clinical evaluation, staging, and routes of disease spread (local and distant)
• Summarize potential treatment modalities including optimum beam and radiation sources, volume and dose calculations, as well as fractionation
• Discuss follow-up treatment and evaluation, patterns of failure, and normal tissue effects
• Discuss the use of multimodality therapies including sequence, interactions, and specific agents
• Describe brachytherapy applications and issues for all disease sites
• Outline the use of palliative care for brain, hepatic and skeletal lesions, plus various obstructive scenarios
• Implement a basic program of ethics, patient safety and quality assurance in clinical practice